A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Effect of Romiplostim on Health-Related Quality of Life in Children with Primary Immune Thrombocytopenia and Associated Burden in Their Parents.
Mathias, Susan D. MPH; Li, Xiaoyan PhD; Eisen, Melissa MD; Carpenter, Nancy MSc; Crosby, Ross D. PhD; Blanchette, Victor S. FRCP
Pediatric Blood & Cancer.
63(7):1232-1237, July 2016.
(Format: HTML, PDF)